Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation

Blood Cancer Journal, Published online: 26 June 2023; doi:10.1038/s41408-023-00867-xMonitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation

Source: Blood Cancer Journal - June 26, 2023 Category: Hematology Authors: Jong-Mi Lee Ari Ahn Eun Jeong Min Sung-Eun Lee Myungshin Kim Yonggoo Kim Source Type: research